Related Experiment Video
Updated: Mar 27, 2026
Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023
Nanoscale Quantifying the Effects of Targeted Drug on Chemotherapy in Lymphoma Treatment Using Atomic Force
Abstract:
The applications of targeted drugs in treating cancers have significantly improved the survival rates of patients. However, in the clinical practice, targeted drugs are commonly combined with chemotherapy drugs, causing that the exact contribution of targeted drugs to the clinical outcome is difficult to evaluate. Quantitatively investigating the effects of targeted drugs on chemotherapy drugs on cancer cells is useful for us to understand drug actions and design better drugs. The advent of atomic force microscopy (AFM) provides a powerful tool for probing the nanoscale physiological activities of single live cells. In this paper, the detailed changes in cell morphology and mechanical properties were quantified on single lymphoma cells during the actions of rituximab (a monoclonal antibody targeted drug) and two chemotherapy drugs (cisplatin and cytarabine) by AFM. AFM imaging revealed the distinct changes of cellular ultramicrostructures induced by the drugs. The changes of cellular mechanical properties after the drug stimulations were measured by AFM indenting. The statistical histograms of cellular surface roughness and mechanical properties quantitatively showed that rituximab could remarkably strengthen the killing effects of chemotherapy drugs. The study offers a new way to quantify the synergistic interactions between targeted drugs and chemotherapy drugs at the nanoscale, which will have potential impacts on predicting the efficacies of drug combinations before clinical treatments.
Insights
Atomic force microscopy quantified how rituximab (a targeted cancer drug) enhances chemotherapy drugs like cisplatin and cytarabine. This research reveals synergistic drug interactions at the nanoscale, improving cancer treatment strategies.
Area of Science:
- Biophysics
- Nanotechnology
- Cancer Research
Background:
- Targeted cancer drugs improve survival but their exact contribution is unclear when combined with chemotherapy.
- Understanding drug interactions is crucial for developing effective cancer therapies.
Purpose of the Study:
- To quantitatively investigate the effects of targeted drugs combined with chemotherapy on cancer cells using atomic force microscopy (AFM).
- To explore the synergistic interactions between rituximab and chemotherapy drugs (cisplatin, cytarabine) at the nanoscale.
Main Methods:
- Utilized atomic force microscopy (AFM) to probe nanoscale physiological activities of single live lymphoma cells.
- Quantified changes in cell morphology and mechanical properties using AFM imaging and indenting.
- Analyzed statistical histograms of cellular surface roughness and mechanical properties.
Main Results:
- AFM imaging revealed distinct changes in cellular ultramicrostructures induced by rituximab, cisplatin, and cytarabine.
- AFM indenting measured alterations in cellular mechanical properties post-drug stimulation.
- Rituximab significantly enhanced the killing effects of chemotherapy drugs, as shown by quantitative AFM analysis.
Conclusions:
- AFM provides a novel method for quantifying synergistic interactions between targeted and chemotherapy drugs at the nanoscale.
- This approach can aid in predicting the efficacy of drug combinations before clinical application.
- Findings offer insights into optimizing combination cancer therapies.
More Related Videos
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017